Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1J-tube----1件: 6 💬
2J01gb01----1件: 299 💬
3J05A F01----1件: 135 💬
4J06ba02----1件: 309 💬
5J1081----1件: 56 💬
6J695----1件: 96 💬
7J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0----1件: 96 💬
8JAK 3----1件: 46 💬
9JAK 3 ritlecitinib----1件: 46 💬
10JAK inhibitor----4件: 46, 50, 97, 325 💬
11JAK1 / JAK2 inhibitor----1件: 46 💬
12JAK1 / JAK2 inhibtor----1件: 46 💬
13Jaki----1件: 46 💬
14Jaktinib1件: Jaktinib---1件: 271 💬
15Jaktinib hydrochloride tablets1件: Jaktinib---2件: 85, 271 💬
16Janus kinase inhibitor----4件: 46, 97, 110, 162 💬
17Jardiance1件: Empagliflozin1件: Empagliflozin 💬 --2件: 65, 86 💬
18Jbpos01011件: JBPOS0101---1件: 145 💬
19JBT-1011件: Lenabasum1件: Lenabasum 💬 1件: CNR2 💬 1件: Neuroactive ligand-receptor interaction 💬4件: 49, 50, 51, 299 💬
20JBT101----1件: 299 💬
21JE049----1件: 65 💬
22Jejunal extension tube----1件: 6 💬
23Jevity 1.0----1件: 2 💬
24Jevity 1.5----1件: 2 💬
25JH-DSA SEMI-quant screen and response score----1件: 60 💬
26JHL1101----1件: 46 💬
27Jianpixiaozhong particles and wuse dietotherapy----1件: 222 💬
28JIN-shui HUAN-xian granule----1件: 85 💬
29Jinarc1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
30Jinarc - 15 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
31Jinarc - 30 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
32Jinarc - tolvaptan tablets1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
33Jinarc 15 MG tablets, jinarc 45 MG tablets1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
34Jinarc 30 MG tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
35Jinarc 30 MG tablets, 90 MG tablets1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
36Jinarc 30 MG tablets, jinarc 60 MG tablets1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
37Jinarc® 15MG tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
38Jinarc® 30 tablet1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬1件: 67 💬
39Jing SI herbal TEA liquid packets----2件: 46, 271 💬
40JKB-122----1件: 95 💬
41JKB-122 IN capsule or tablet form----1件: 95 💬
42JM-010----1件: 6 💬
43JM-010 group A----1件: 6 💬
44JM-010 group B----1件: 6 💬
45JM-4----1件: 13 💬
46JMKX000189----1件: 49 💬
47JMKX003142 will BE administered orally----1件: 67 💬
48JNJ 38518168----1件: 46 💬
49JNJ 54767414----1件: 28 💬
50JNJ-16240159-AAC----1件: 46 💬
51JNJ-31001074----1件: 6 💬
52JNJ-38518168----1件: 46 💬
53JNJ-38518168 / MTX----1件: 46 💬
54JNJ-38518168 50-MG over encapsulated tablet----1件: 46 💬
55JNJ-38518168-AEK - over encapsulated tablet - 50 MG----1件: 46 💬
56JNJ-38518168-ZBQ - FILM-coated tablet - 10 MG----1件: 46 💬
57JNJ-38518168-ZBQ - FILM-coated tablet - 10MG----1件: 46 💬
58JNJ-38518168-ZBQ - FILM-coated tablet - 3 MG----1件: 46 💬
59JNJ-38518168-ZBQ - FILM-coated tablet - 30 MG----1件: 46 💬
60JNJ-38518168-ZBQ - FILM-coated tablet - 30MG----1件: 46 💬
61JNJ-38518168-ZBQ - FILM-coated tablet - 3MG----1件: 46 💬
62JNJ-39039039----1件: 210 💬
63JNJ-397589791件: JNJ-39758979---1件: 46 💬
64JNJ-39758979 / MTX1件: JNJ-39758979---1件: 46 💬
65JNJ-39758979-AAC - enteric coated tablet - 10 MG1件: JNJ-39758979---1件: 46 💬
66JNJ-39758979-AAC - enteric coated tablet - 100 MG1件: JNJ-39758979---1件: 46 💬
67JNJ-39758979-AAC - enteric coated tablet - 30 MG1件: JNJ-39758979---1件: 46 💬
68JNJ-403465271件: JNJ-40346527---1件: 46 💬
69JNJ-40346527-AAC1件: JNJ-40346527---1件: 96 💬
70JNJ-40346527-AAC - capsule - 50 MG1件: JNJ-40346527---1件: 46 💬
71JNJ-42160443----1件: 226 💬
72JNJ-54767414----2件: 28, 49 💬
73JNJ-54781532 150 MG once daily----1件: 97 💬
74JNJ-54781532 25 MG once daily----1件: 97 💬
75JNJ-54781532 75 MG once daily----1件: 97 💬
76JNJ-54781532 75 MG twice daily----1件: 97 💬
77JNJ-54781532-AAD-10 MG----1件: 97 💬
78JNJ-54781532-AAD-30 MG----1件: 97 💬
79JNJ-54781532-AAD-5 MG----1件: 97 💬
80JNJ-55920839----1件: 49 💬
81JNJ-56022473----1件: 49 💬
82JNJ-64304500----1件: 96 💬
83JNJ-64304500-AAA----1件: 96 💬
84JNJ-64841829----1件: 97 💬
85JNJ-64841842----1件: 97 💬
86JNJ-64841855----1件: 97 💬
87JNJ-64841894----1件: 97 💬
88JNJ-64841907----1件: 97 💬
89JNJ-64841920----1件: 97 💬
90JNJ-64841933----1件: 97 💬
91JNJ-64841946----1件: 97 💬
92JNJ-66525433----1件: 97 💬
93JNJ-67484703----1件: 46 💬
94JNJ-67864238----1件: 96 💬
95JNJ-67896049----1件: 86 💬
96JNJ-67896062 / ACT-064992----2件: 86, 88 💬
97JNJ-67896062/ACT-064922----1件: 86 💬
98JNJ-67896153/ACT-128800----1件: 13 💬
99JNJ-72537634----1件: 97 💬
100JNJ-77242113----2件: 37, 97 💬
101JNJ-78934804----2件: 96, 97 💬
102JNJ-79635322----1件: 28 💬
103JNJ-80202135----4件: 11, 46, 49, 53 💬
104JNJ31-31001074----1件: 6 💬
105JNT-517 suspension1件: JNT-517---1件: 240 💬
106JNT-517 tablet1件: JNT-517---1件: 240 💬
107Joint puncture----1件: 107 💬
108Jojoba OIL with broccoli sprout extract1件: Jojoba oil---1件: 36 💬
109Jorveza1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
110Jorveza 0.5 MG compresse orodispersibili1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
111Jorveza 0.5 MG orodispersible tablets1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
112Jorveza 1 MG compresse orodispersibili1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
113Jorveza 1 MG orodispersible tablets1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
114JP 1730----1件: 6 💬
115JP-1730/F01----2件: 6, 17 💬
116JP-1730/F02----2件: 6, 17 💬
117JP-1730/F03----2件: 6, 17 💬
118JR-141----1件: 19 💬
119JR-141 or idursulfase1件: Idursulfase1件: Idursulfase 💬 1件: IDS 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
120JR-171----1件: 19 💬
121JR-441----1件: 19 💬
122JR-446----1件: 19 💬
123JS002----1件: 79 💬
124JS005----1件: 271 💬
125JSP191----2件: 65, 285 💬
126JTE-051----1件: 46 💬
127JTT-2511件: JTT-251---1件: 86 💬
128Juanbi pill----1件: 46 💬
129Juvit D3----1件: 6 💬
130JWK006----1件: 301 💬
131JWK007 single intravenous infusion administration----1件: 113 💬
132JWK008 single intravenous infusion administration----1件: 19 💬
133JX2105----1件: 6 💬
134JY231 injection----1件: 49 💬
135JYP0061----1件: 13 💬
136Jyseleca1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
137Jyseleca 100 MG FILM-coated tablets1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
138Jyseleca 100MG FILM-coated tablets1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
139Jyseleca 200 MG FILM-coated tablets1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
140JZP-110----1件: 6 💬
141JZP385----1件: 6 💬